MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma.
Anticancer Agents Med Chem
; 21(2): 246-253, 2021.
Article
in En
| MEDLINE
| ID: mdl-32416702
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Doxorubicin
/
Carcinoma, Hepatocellular
/
MicroRNAs
/
Liver Neoplasms
/
Antibiotics, Antineoplastic
Limits:
Humans
Language:
En
Journal:
Anticancer Agents Med Chem
Journal subject:
ANTINEOPLASICOS
/
QUIMICA
Year:
2021
Document type:
Article
Affiliation country:
Egipto
Country of publication:
Países Bajos